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ABSTRACT 
 
It is well known obesity rates have climbed steadily since the 1960s. The result is 
an increasing burden on healthcare in the world and especially, the United 
States.  Those costs are not simply financial, but obesity, defined as a chronic 
disease of excess fat, has many comorbid diseases associated with it, along with 
decreased productivity and happiness.   Trends in depression of the past few 
decades mirror those of obesity, as depression is more prevalent than ever. 
Likewise, depression places a heavy burden on the healthcare infrastructure.  
Many different researchers have sought a link between these two chronic 
diseases, and it is the goal of this paper to review this evidence.  Investigators 
have framed the potential relationship in many different ways, including a 
sociological argument, with either obesity or depression predisposing the other, 
being elements in a shared inflammatory pathway, CNS pathway, HPA axis, and 
serotonin pathway.  More studies are needed to conclude there is a definitive link 
between obesity and depression, but because of the massive toll both conditions 
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take on the individual and society, it is well worth the investment.  Perhaps, the 
success of obesity treatments that address depression, diminished self-worth 
and self-esteem provide some promise, and they also provide a new avenue to 
study this relationship.  In identifying the comprehensive approaches to obesity 
that are most effective, researchers may be able to work backwards, identifying 
all the elements being touch upon by the treatment.    
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INTRODUCTION 
 
Obesity is a chronic disease of a person having excess fat, primarily defined in 
terms of a body mass index (BMI) equal to or greater than 30 kg/m2, which is 
calculated by dividing an individual’s mass by their height.  Obesity is also a 
multifactorial disease that likely results from an interaction of genetic, metabolic, 
social, behavioral, and cultural factors (National Institutes of Health, 1998).  In 
2008, the World Health Organization estimated there are over 200 million men 
and approximately 300 million women in the world who are obese (WHO, 2012). 
No longer is obesity solely a burden on developed countries; middle-income and 
low-income countries have seen upward trends in obesity as well, more notably 
in urban environments (WHO, 2012).  For this reason, obesity is considered a 
global epidemic (Wadden et al., 2002).  The rate of obesity in the United States is 
among the highest in the world and as such great attention should be paid to 
developing treatment and prevention strategies. The rate of obesity has climbed 
by 50% from the late 1970’s, which in terms of body weight translates into a 6 lb. 
weight gain for a male or female adult (Chou et al., 2004).  
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Table 1 amended from Chou et al., 2004.  Trends in Body Mass Index and the 
Percentage Obese, Persons 18 Years of Age and Older. 
NHES 1=First National Health Examination Survey.  NHANES I=First National 
Health and Nutrition Examination Survey, NHANES II =Second National Health 
and Nutrition Examination Survey, NHANES III=Third National Health and 
Nutrition Examination Survey, and NHANES 99=National Health and Nutrition 
Examination Survey 1999–2000. Body mass index calculated by weight in 
kilograms divided by height in meters squared. Actual weights and heights were 
used in calculation.  Percentage of the population with a BMI≥30 kg/m2. In NHES 
I survey, 2 lbs. were subtracted from actual weight to account for the weight of 
their clothing. 
 
Table 1 
Trends in Body Mass Index and the Percentage Obese, Persons 18 Years of 
Age and Older 
Survey Period Body mass index Percentage obese 
NHES I 1959–1962  24.91 12.73 
NHANES I    1971–1975 25.14 13.85 
NHANES II   1976–1980 25.16 13.95 
NHANES III    1988–1994 26.4 21.62 
NHANES 99  1999–2000 27.85 29.57 
 
Table 1 summarizes the progression of obesity from approximately 13 percent of 
the U.S. population being obese in 1960 to approximately 30 percent of the U.S. 
population in 2000.  The data seen in Table 1 begins to outline the levity of the 
obesity epidemic affecting the world and the United States, and consequently, 
why obesity has generated so much interest in health care. 
 
Continuing with the description of the obesity epidemic, from the National Center 
for Health Statistics (NCHS) January 2012 data brief, in 2009-2010, more than 
78 million U.S. adults and roughly 12.5 million U.S. children and adolescents 
were obese, and in 2010, more than a third of the United States adult population 
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was categorized as obese, estimated to be 35.7% (Flegal et al., 2012). Based 
upon the information from Table 1, the trend over the past several decades is a 
steady rising rate in the number of individuals classified as obese. 
 
 
Figure 1 taken from Wang et al., 2008. Prevalence of Obesity and Overweight 
among US Adults: Observed during 1976–2004 and Projected. Linear regression 
models used for projected prevalence. 
 
Until present day, the depiction of the obesity landscape with respect to 
healthcare has been alarming.  Figure 1 projects the percentage of the 
population who are obese beyond 2004 for the next 50 years and 100 years.  It is 
particularly noteworthy because within a century, the entire population will be 
considered obese.  Of course, there isn’t anyway for scientists to predict the 
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future, but as measured, if the reality of the obesity epidemic lands anywhere 
close to this prediction, the ramifications will be absolutely devastating.  This 
linear regression model of the next 100 years was limited to adults; so perhaps, 
one can be optimistic about an improvement in the next generation.   
 
Unfortunately, much of the evidence argues this is not the case, as the younger 
generation has also charted rises in obesity leading only to a heighted urgency to 
the problem.  In fact, young adults, ages 18-29 years, have seen the a 
disproportionate increase in obesity, more so than all other age groups, which 
supposes adolescence as a critical risk period for obesity (Goodman et al., 
2002).  This is particularly frustrating for the healthcare community because 
obesity is preventable (WHO, 2012).  It would be logical the best approach to 
adult obesity is to target overweight and obese children and adolescents.  If we 
have healthier children, we should expect to have healthier adults.  An added 
benefit to identifying those most at risk to develop obesity, such as young adults, 
is to ensure proper energy and resources are appropriated to those most in 
need.  According to the 1998 evidence report by the National Heart, Lung, and 
Blood Institute (NHLB), groups most affected by obesity include black and Latino 
minority groups compared to U.S. whites, women, the less educated, and those 
earning lower incomes (Clinical Guidelines, 1998).  Studies yielding this type of 
data should continue because we need to keep assessing the highest risk 
groups, and in doing so, where we may begin our most aggressive course of 
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action to prevent treat obesity.  An important observation from Table 2, created 
from data taken from the National Health and Nutrition Examination Surveys, is 
from 1960-1994 no gender, race, or ethnicity is spared in the upward trend of 
BMI. 
Table 2 amended from Clinical Guidelines, 1998.	  	  
Prevalence of Obesity (BMI≥30.0 kg/m2) Among Adults Age 20 to 80+ years, 
by, Gender, Race/Ethnicity, and Age: United States, 1960-1994. 
  NAHES I 
NHANE
S I 
NHANE
S II 
NHANE
S 
NHANE
S III 
Gender, race/ethnicity, 
age 20 years and 
older, age adjusted: 1960-62 1971-74 1976-80 1982-84 
1988-
94 
  
(age 20–
74) 
(age 20–
74) 
(age 20–
74) 
(age 20–
74) 
(age 
≥20) 
Both Sexes 12.8 14.1 14.4   22.3 
Men 10.4 11.8 12.2   19.5 
Women 15.1 16.1 16.3   25 
White men 10.1 11.4 12   20 
White women 13.7 14.7 14.9   23.5 
Black men 13.9 15.9 15.2   20.6 
Black women 25 28.6 30.2   36.5 
White, non-Hispanic 
men     12   19.9 
White, non-Hispanic 
women     14.8   22.7 
Black, non-Hispanic 
men     15   20.7 
Black, non-Hispanic 
women     30   36.7 
Mexican-American 
men       15.4 20.6 
Mexican-American 
women       25.4 33.3 
 
Aside from obesity’s deep impact on global and American epidemiology, obesity 
is such a devastating disease because it is associated with several comorbid 
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conditions, responsible for premature morbidity, and under-treated by healthcare 
practitioners (Rippe et al., 1998). Obesity is associated with elevated risk of 
endometrial, breast, prostate, and colon cancers, high blood pressure, high blood 
cholesterol, heart disease, stroke, diabetes, arthritis, breathing problems, chronic 
back pain, and joint disease (Centers for Disease Control, 2003; Onyike et al., 
2003).  Cross-sectional and longitudinal studies have revealed obesity’s effect on 
developing gallbladder disease, as obese individuals experience gallstones at 3-
4 times the rate as non-obese individuals, and an effect of obesity was reported 
on elevated levels of uric acid and prevalence of gout (Pi-Sunyer, 1993).  
Because obesity is so complex and many systems are affected throughout the 
body, research has also been conducted on the impact obesity may have on 
lifespan and morbidity.	  
 
The results of such research are probably to be expected.  Obesity causes the 
second largest number of preventable deaths, approximately 280,000 adult 
deaths per year (Latner, 2001).  In the range of 100,000 to 400,000 premature 
deaths can be attributed in part to obesity (Hammond et al., 2010). White males 
were projected to have the most years of life lost (YLL) due to obesity, for 
example a 20 year old white male with a BMI of 45 kg/m2 may be expected to 
have 13 YLLs (Wang et al., 2008).  As a result of the wide-ranging effects of 
obesity, the toll on the individual is great and the cost burden on the health care 
infrastructure is immense. 
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By and large, the reason to sketch this picture of obesity epidemiologically and 
clinically of the past, present, and future is to convey the levity of this epidemic 
and to solicit new and creative approaches to this epidemic. I argue for the 
consideration of the psychology, particularly depression or depressive symptoms, 
to be addressed in the treatment of those who suffer from obesity.  This idea of 
confronting the psychological issues of those suffering from obesity is predicated 
on the notion there is a real and significant relationship between obesity and 
psychological problems, particularly depression.  Researchers have invested a 
lot of time and energy into legitimizing this relationship, and it absolutely makes 
sense to do so, as depression is causing a monumental burden on the 
healthcare infrastructure as well. 
  
Our population is also more depressed than previous generations, yet the similar 
pattern in prevalence to obesity is not the only evidence leading researchers to 
believe a relationship exists (Blaine, 2008; Goodman et al., 2002; Miller et al., 
2003, Weber-Hamann et al., 2002).  Decades of research have defined a very 
real and negative stigma associated with obesity.  Intuitively, it would make 
sense that such a societal stigma may have damaging effects on one’s psyche 
(Freidman et al., 1995). It is also plausible the causation may, in fact, work in the 
opposite direction, by way of a depressive mood affecting likelihood of 
developing obesity (Blaine, 2008).  
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Beyond aligning obesity and depression via sociology and societal pressures, 
similarities in mechanisms of pathology also exist and have been targeted by 
researchers to uncover information. Some see the story to lie with inflammation, 
told through corresponding levels of inflammatory markers, such as IL-6 or TNF-
α (Ikeoka et al., 2010). Other molecular mediators also have been investigated 
as a means of affecting depression, serotonin (5-HT) and leptin being two 
examples (Rosmond, 2004). Studies focusing on central obesity may predict 
depressive symptoms through cortisol (Weber-Hamann et al., 2002). Yet not all 
studies have corroborated this notion; many of the preliminary studies concluded 
an inconsistent relation between obesity and depression (Onyike et al., 2003). 
However obesity and depression may be linked, the scientific community is 
hopeful at the prospect of investigating it further so that healthcare practitioners 
may devise a better healthcare approach to treatment.  
 
In a pattern similar to obesity, there has been an exponential increase in 
depression rates in recent years.  In 2012, according to the World Health 
Organization, more than 350 million are thought to be clinically depressed around 
the world (WHO, 2012).  In the United States, over 235,000 are estimated to be 
depressed (CDC, 2013). In 2000, Greenberg estimated health costs related to 
depression to be approximately $80 billion (Greenberg, 2003). Spanning from 
1991-1992 to 2001-2002, depression in adults has doubled, and an estimated 
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20% of adults are at some point affected by depression (Dave et al., 2011).  
These statistics have certainly placed depression on the radar of many health 
care providers.   
 
As a result of these parallel upward trends, many researchers have investigated 
both obesity and depression looking for either an association or causality.  
Because evidence reveals both diseases enhance risk of mortality, coronary 
heart disease, hypertension, and diabetes, some see promise there may be a 
link (Olszanecka-Glinianowicz et al., 2009).  Chronic inflammation is a symptom 
of both obesity and depression as well.  Olszanecka-Glinianowicz and her group 
explored the connection further by isolating the inflammatory markers 
(Olszanecka-Glinianowicz et al., 2009).  Other scientists have approached the 
potential relationship with a more psychological perspective, focusing more on 
mindset and attitudes of those persons with the disease. 
 
Beyond the numbers describing the obesity epidemic, the quick onset is also 
alarming. These staggering statistics have left health care practitioners 
scrambling to find what causes obesity, relatively recent surges in obesity rates, 
and just as important, how do they go treat it moving forward. This paper’s aim is 
to strengthen the argument for a relationship between obesity and depression 
and if possible, provide insight into the direction of that relationship of which 
disease predisposes for the other.  It will briefly explore the evidence supporting 
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the pathophysiological and psychological connection between the two conditions.  
It is important to do so because strong evidence has been presented that weight 
loss in obese individuals to lower risk for diabetes, cardiovascular disease, and 
blood pressure, and reduces serum triglycerides, to an extent total serum 
cholesterol, low-density lipoprotein-cholesterol, and blood glucose levels in those 
with and without diabetes, and increases high-density lipoprotein-cholesterol 
(Clinical guidelines, 1998).  Therefore, in order to reap the benefits of weight 
loss, the healthcare community must invest heavily in a comprehensive treatment 
strategy.  Currently, the approach is a multi-faceted, including “diet therapy, 
altering physical activity patterns; behavior therapy techniques; 
pharmacotherapy; surgery; and combinations of these techniques” (Clinical 
Guidelines, 1998).  Others argue for changes in our environments to make them 
safer and more conducive to exercise, legislation, and food accessibility to 
address some of the deeper-rooted problems manifested in the obesity epidemic 
(Dean et al., 2011).  The goal is to push the debate further towards the 
psychological component being included in treatment, so we may treat 
depression, resulting from or causing obesity, in the form of anti-depressants, 
literature, counseling, support group, empowerment, targeting specific 
inflammatory markers to reduce inflammation, or via a treatment not yet in the 
literature.  Those who are obese shouldn’t be left to alone.  In fact, they should 
be surround with community of support including the family, school, and 
community in fostering an environment where a healthy lifestyle is promoted. 
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Likewise, the healthcare community shouldn’t approach obesity singularly; a 
team of experts is necessary to turn the trend around, and perhaps that team 
includes a psychologist. 
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ETIOLOGY 
 
To begin, it is appropriate to discuss the etiology of obesity, which is shaped by 
several factors including, lifestyle, environmental, biological, and nutritional. Dr. 
George Bray has famously divided the cause of obesity between genes and 
environment.  Between 25% and 40% of the variation can be attributed to 
genetics  (Wadden et al., 2002).  However, the focus of this paper will be on the 
factors that the individual and society are able to affect.  In order to give insight 
into how the obesity epidemic came to be, it is helpful to take a step back and 
view the progression of society as a whole. 
 
Our culture has evolved over thousands of years from depending on hunting, 
gathering, and farming as a means to provide food to heavy reliance on 
technology and a sedentary lifestyle; technology has largely replaced the need 
for human manual labor, and in doing so, modern society’s reliance on 
technology has affected the amount of physical activity in our daily lives 
immensely (Department of Health and Ageing, 1999).  The sum of these factors 
have led to a more sedentary lifestyle, one in which we expend less energy.  The 
comparison of Pima Indian Women of the Arizona to the Pima Indian women of 
Mexico provides good evidence for the contribution of lifestyle to BMI.  After 
essentially controlling for the effect of genetics because they are of the same 
ancestry and have only been separated by a political barrier, one observes an 
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average BMI of 37 kg/m2 of the women in Arizona and an average BMI of 
25kg/m2 of the women in Mexico (Wadden et al., 2002).  The main appreciable 
difference between the groups of women is the American environment to which 
the Pima Indian Women in Arizona are exposed, and a big part of that American 
environment and culture is television. 
 
The role of television in society is often times taken for granted, but television’s 
influence in our lives is undeniable and relevant to the discussion of obesity, 
especially when it comes to children. Pediatric researchers Dietz and Gortmaker 
evaluated the impact of television on obesity in children.  They concluded that an 
hour increase in television watching corresponded to a 2% higher chance of 
obesity (Dietz et al., 1985).  American children watch an average of 28 hours of 
television per week (Wadden et al., 2002).  If you couple the decrease in activity 
level with the changes in the average diet, the picture of the emergence of 
obesity starts to become clearer.   
 
Nutrition is clearly essential to the dialogue of the obesity epidemic.  The 
unprecedented exposure to cheap and energy dense food is dangerous because 
obesity is a function of an individual’s energy balance, defined as the difference 
between calories consumed and expended (Wadden et al., 2002). Gender, 
genetics, race, and ethnic background are among many other factors influencing 
cumulative energy balance as well (Chou et al., 2004).   
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Besides changes in lifestyle and the higher caloric density of the foods, the way 
people are eating is different (Ledikwe et al., 2005). Perhaps, what’s on the 
dinner plate is a window into our values.  Reflected in our purchased foods is the 
immediacy that our society values, diets rely heavily on snacks, ready-made 
meals, and fast food, which tend to have more fat (Lester, 1994).  Corresponding 
with rapid increases in obesity beginning in the late 1970’s, the number of fast 
food restaurants has exploded (Ledikwe et al., 2005).  The explosion of fast food 
restaurants may be in reaction to changing social and family dynamics that afford 
less time at home dedicated to preparing and cooking meals.  Regardless for the 
reason, Chou et al. attributed 65% of the rise of obesity prevalence to the upward 
trend of restaurants per capita (Chou et al., 2004).  A gross oversimplification of 
the problem would be to say all people need to do is eat less, but there is 
evidence obese people eat more high-energy dense food than non-obese people 
(Ledikwe et al., 2005). These types of studies, looking at food habits, are 
valuable in the insight given into what drives those food choices, mainly a 
decreasing food price, a heavier reliance on fast food, and maybe, less priority 
placed on meals prepared in the household. 
 
Both social and government policy has facilitated a transition to prominent use of 
motor vehicles for transportation, as opportunities for physical exercise have 
diminished (Dean et al., 2012). As our lifestyles slowly become increasingly void 
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of physical activity, people may be devaluing the importance of physical activity 
(WHO, 2012).  Some schools certainly are (Wadden et al., 2002).  Society may 
be marginalizing physical activity in our lives for the sake of convenience and 
efficiency, but in the process, losing sight of they physical benefits. The decisions 
on the larger scale of our neighborhoods, schools, local and federal government 
are also contributing to the surging number of obese individuals in society.  To 
move forward with a solution, it is best to know all the factors defining the 
problem. 
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COSTS 
 
In the United States, the upward trend of obesity is undeniable and costly. 
Upwards of $215 billion was the estimate of the total economic costs of obesity in 
2010, including direct and indirect medical costs (Hammond et al., 2010).  Direct 
healthcare costs were approximately $147 billion; compared to a non-obese 
person, an obese person costs $1500 more (CDC, 2003). With respect to a 
normal weight adult, an obese individual may be expected to incur higher relative 
medical costs.   Another way to frame the economic burden of obesity would be 
in context of insurance.  If one eliminates the costs of obesity, you’d see an 8.5% 
and 11.8% reduction in Medicare and Medicaid spending (Hammond et al., 
2010).   
 
Many aspects of society are paying for the repercussions of this obesity epidemic 
beyond financial burdens. These include productivity losses in the form of being 
absent from work, having diminished efficiency while at work, increased disability 
insurance premiums, and shortened lifespan; societal costs, such as, elevated 
transportation costs to accommodate larger bodies, an emotional toll resulting in 
a damaged self esteem, and inclusive studies hint at the potential for higher 
school absenteeism and lower grade point averages among youth (Hammond et 
al., 2010).  Hammond and Levine provided a review that addressed the finances 
beyond those directly pertaining to diagnosis, treatment, and other comorbid 
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diseases which is unlike many researchers before them.  Indirect costs are 
significantly harder to quantify, and consequently, many papers chose not 
include them in analysis.  However, it is very important to do so because the 
picture is not complete without them, and the impact of the disease for which 
society must plan may be underestimated.  Within this more inclusive estimation, 
the toll on the psyche of these obese individuals can start to be seen.  Likewise, 
no one person lives in isolation, and as a result, this psychological toll can also 
impact communities in which these people live and function.  
 
Table 3 succinctly summarizes the direct and indirect costs attributed to obesity.  
Childhood obesity is directly responsible for $14.3 billion annually in medical 
costs.  Employees missing works days accounts for approximately $3.4-6.4 
billions dollars, in addition to diminished productivity.   Up to 13 years cut from life 
expectancy, a 5.6-6.9% elevated chance of going onto disability, $742 million 
dollars added due to fuel costs, more days missed from school, and ending 
school at a lower grade can be attributed to obesity. These models may begin to 
better paint the landscape for the challenges our healthcare leaders are facing 
today by including the financial and societal price of obesity. It is a difficult task to 
assign a price tag on any disease, not to mention a disease, so pervasive as 
obesity, but how else will a debt be paid without first appraising how much is 
owed.   
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Table 3 taken from Hammond et al., 2010.  The Key Costs Identified from 
Research on the Economic Impact of Obesity. 
 
Cost Category 
Sub-
categories 
Key results, and range 
of estimates Relative 
Costs Total Costs 
Direct Medical 
Spending   
Annual direct costs of 
childhood obesity   $14.3 billion 
    
US-wide annual cost of 
“excess” medical 
spending attributable to 
overweight/obesity   
$86-147 
billion (total) 
Productivity 
Costs  
Absenteesim Excess days of work due 
to obesity 
  
  
    
Relative risk ratio of 
having 'high absenteeism' 
1.24-1.53 
times higher   
    
National costs of annual 
absenteeism from obesity   
$3.38-$6.38 
billion 
  
Presenteesim National annual costs of 
presenteeism from 
obesity 
  
  
  
  Relative productivity loss 
due to obesity 1.5% higher   
  
Disability Relative risk ratio of 
receiving disability 
income support 
5.64-6.92% 
higher   
  
Premature 
Mortality 
Years of life lost due to 
obesity 
 1-13 
yrs/person  
 
  
Total National annual indirect 
costs of obesity   $66 billion 
Transportation 
Costs 
Fuel Costs Annual excess jet fuel 
use attributable to obesity   $742 million 
  
Environmental 
Costs 
OECD-wide CO2 
emissions from 
transportation PER 5 kg 
average weight per 
person     
Human Capital 
Costs   
Highest grade completed 0.1-0.3 
fewer 
grades 
completed    
    
Days absent from school 
1.2-2.1 more 
days absent 
from school   
 
 
 
19 
 
What makes those waging the fight against the obesity epidemic even more 
concerned is the evidence proposing the upward trend may continue.  In a look 
at health care costs projected through 2030, Wang and his group of researchers 
estimated direct medical costs of obesity, related to the prevention, diagnosis, 
and treatment service, given a continued uniform progression of the disease. 
Wang et al. ultimately estimated costs to range from $860 to $956 billion, 
translating into 1/6th of the American budget spent on health care costs, and his 
data also showed 51.1% prevalence of obesity of adults in the United States in 
2030, and by 2048, 100% prevalence of overweight or obesity would be seen 
(Wang et al., 2008).   
 
The study has many limitations.  Most notable is the essentially linear model 
used to predict prevalence and costs.  Although it is unlikely the statistics will 
conform neatly to the linear projections reported, estimations even close are 
disturbing.  Wang and his group give a context to the already alarming statistics 
describing the obesity epidemic in present day and how they will likely worsen. 
The study reinforces the sense of urgency for a solution to what many seem as a 
preventable disease in obesity.  
 
Not only do obesity and depression share many of the same comorbid 
conditions, a similar trend of ascension, a heavy health and emotional toll on the 
affected person, but they also place a comparable financial burden on healthcare 
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resources. To compute the total costs of depression in 2000 in the United States, 
Greenberg et al. used an analysis model that mirrored those used in obesity 
estimations comprised of three components, costs related to direct treatment, 
suicide, and work setting, especially missing work and decreased productivity 
(Greenberg et al., 2003).  He went on to define each of the three components.  
Direct medical costs consisted of outpatient and inpatient hospital admittance, 
nursing home admittance, and pharmaceutical sales of anti-depressants, 
depression-related suicide costs were calculated from the number of suicides 
reported in 2000, according to the Center for Disease Control and the lifetime 
earnings that would be missed from a shortened life, and lastly, workplace costs 
were defined as the revenue lost to a decline in productivity while at work or days 
absent from work attributable to depression or depression episodes (Greenberg 
et al., 2003).  The cost breakdown analysis resulted in the following; in 2000, 
there was $83.1 billion in total healthcare costs, of which $26.1 billion was 
attributed to direct medical costs, $5.4 billion to suicide-related costs, and $51.5 
billion to workplace costs (Greenberg et al., 2003). Perhaps, the most staggering 
statistic is comparing estimated costs from 1990 to those of 2000, as they have 
nearly doubled in that 10-year time span as seen in Table 4.   
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Table 4 amended from Greenberg et al., 2003.  Economic Burden of Depression, 
1990 Versus 2000. 
 
Economic Burden of Depression, 1990 Versus 2000 
  1990 (in U.S. dollars) 2000 
Type of Cost Dollars (in millions) 
Percentage 
of Total 
Dollars(in 
millions) 
Percentage 
of Total 
Direct costs 19,883 25.7 26,087 31.4 
Inpatient 13,368 17.3 8,883 10.7 
Outpatient 4,632 6.0 6,803 8.2 
Pharmaceutical 1,882 2.4 10,400 12.5 
Suicide-Related 
costs 5,584 7.2 5,450 6.6 
Workplace costs 51,888 67.1 51,543 62.0 
Absenteeism 39,450 51.0 36,248 43.6 
Presenteeism 12,439 16.1 15,295 18.4 
Total 77,355 100.0 83,080 100.0 
 
The healthcare costs are staggering of each disease individually, but their totals 
combined overwhelm the healthcare infrastructure.  From Table 4, one can note 
how depression also pervades into indirect costs of the individual, absenteeism, 
presenteeism, and other workplace costs similar to obesity.  How impactful both 
obesity and diabetes are on lifestyle is reflected in cost.  Obviously, the whole 
healthcare community is in agreement that something needs to be done, but 
what is the most efficient way to tackle this challenge.  My argument is by finding 
commonality between obesity and depression treatment can be implemented 
synergistically.  This type of treatment may be more helpful in treating obesity, 
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but will also help to alleviate pressure from two of the most financially devastating 
diseases.  
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DISCUSSION OF ASSOCIATION OF OBESITY AND DEPRESSION 
 
The 5-year prospective study done by Roberts et al. is a good place to start, as 
we review evidence supporting an association between obesity and depression.  
First, it is among the first papers addressing a potential link, prospectively 
drawing from over 2,000 subjects over the age of 50 who have participated in the 
Alameda County Study.  Second, according to the authors, it is the first paper to 
consider reciprocal effects of both diseases (Roberts et al., 2003).  If an 
association exists, it may further help to identify which direction that causality 
moves.  The mental and health data was collected in 1994 and 1999 from a 
community sample in Alameda County, California from a study ongoing for 30 
years.  Surveys, issued in the beginning and end of the study, collected 
information pertaining to psychological well-being and a number of lifestyle 
factors (Roberts et al., 2003).  In addition, measurements were taken of height, 
BMI, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-
IV) criteria for depression, and participants were about 12 chronic medical 
conditions.  In summary, Roberts found obese participants were 2 times as likely 
to be depressed, and depressed participants were 1.8 times more likely to 
become obese (Roberts et al., 2003). 
 
 
Table 5 modified from Roberts et al., 2000. Prevalence of Symptoms of DSM-
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12D (12-item Scale for Major Depressive Episode) Major Depression by Level of 
Obesity in 1994, Alameda County, California, 1994–1995.  p=.001 (chi-square) 
 
1994 Weight 
(measured by BMI) 1994 Depression 
  
Depressed (%) (n 
= 200)  
Not depressed (%) (n 
= 2,098) 
Underweight  8.8 91.2 
Normal  7.4 92.6 
Obese  15.5 84.5 
 
 
 
Upon further examination, however, the observation of depression increasing risk 
of obesity is eliminated after adjusting for the baseline BMI.  In a different sort of 
study such as a cross-sectional study, the data perhaps might lead to a 
significant reciprocal effect of obesity upon depression. Up until 2003, there was 
more evidence to support obesity affecting depression (Blaine, 2008). Due to 
social stigma and environmental factors, it is quite logical to expect such a 
progression.  For example, studies have shown obese women earn less on 
average and are more likely to live impoverished, and obese men are less likely 
to marry, which help explain chronic sentiments of embarrassment shame, and 
guilt (Goodman et al., 2002).  One key limitation of the study by Roberts was the 
exclusion of subjects under the age of 50, and as a result, one can only draw 
conclusions in an older demographic.  The younger generations, who are the 
most vulnerable demographic, are excluded from the study. 
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Focusing on strengthening the argument for an association between obesity and 
depression, Zhao and his team measured obesity in terms of waist 
circumference, and defined obesity as a waist circumference of greater than 102 
cm for men and greater than 88 cm for women (Zhao et al., 2011).  Perhaps they 
framed their discussion of obesity in terms of central obesity because waist 
circumference measurements are less expensive, and some have concluded 
visceral adiposity has a stronger association with heart attack, type 2 diabetes, 
metabolic syndrome, medical care costs, and all-cause mortality risks.  Like most 
preceding it, this study is a cross-sectional study, drawing from a nationally 
represented sample from the National Health and Nutrition Examination Survey 
of 2005-2006. Overall, the overweight or obese sample population displayed 
higher chances of expressing depressive symptoms, even after adjusting for 
other chronic diseases and all major confounders; the data also revealed obese 
female participants between the ages of 40 and 60 years old had a notably 
higher association with major or moderate-severe depressive symptoms (Zhao et 
al., 2011).  
 
As with other cross-sectional studies, one can’t extract any information about 
causality from the Zhao study.  Patient Health Questionnaire-9 was employed to 
assess depressive symptoms, but other studies may choose other approaches to 
diagnose depression. The pool of nearly 2,500 subjects makes a strong case for 
the validity of their data.  Ultimately, neither group could draw definitive 
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conclusions about which disease comes first in causation, but both Roberts and 
Zhao produced strong evidence linking obesity with depression.   
 
One approach to finding a strong association was to narrow the attention to one 
aspect of obesity.  Obesity is often separated into two categories: peripheral 
obesity and central obesity.  Central obesity, meaning fat distribution localized to 
the midsection, has become a popular subject in the scientific community in the 
last decade (Pi-Sunyer, 1993).  Some have argued central obesity is more 
harmful than peripheral obesity (Lee et al., 2005). The scientific community has 
debated the most useful way of measuring central adiposity between waist 
circumference (WC) and waist-to-thigh ratio (WTR), but many argue either 
measurement is more helpful in investigating the harmful effects of obesity than 
BMI.  There may be variance in how muscle, bone, or fat is proportioned in an 
individual for which BMI cannot account (Zhao, 2011). Excess visceral adipose 
tissue particularly augments the rates morbidity and mortality related to obesity 
(Li et al., 2007). Measurements of visceral obesity may indeed be a more useful 
tool in diagnosing obesity, but many see the argument a matter of semantics.   
 
Lee et al. proposes visceral adipose tissue (VAT) may show an even stronger 
association with depression than subcutaneous adipose tissue (SAT) found 
throughout the body.  Results of their analysis showed no association between 
SAT and depression, but did show a significant association between VAT and 
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depression, as reflected in Zung’s Self-Rating Depression Scale (SDS), with 
p=.032 (Lee et al., 2005).  In order to account, for an increasing percentage of 
visceral fats and changes in the profile of sex hormones accompanying 
menopause, the study limited participation to pre-menopausal women (Lee et al., 
2005).  The women who participated in the study were overweight, and upon 
further investigation, a significant corollary may exist for obese persons.  This 
study does not seek to prove it.  Even though overweight individuals have a 
higher risk of becoming obese than non-overweight individuals, there still a 
distinction to be made from not using obese participants.  As is the case with 
most of the other studies on the subject, this is a cross-sectional study, and as a 
consequence, one cannot definitively begin to discuss causation with these 
findings.  
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DEPRESSIVE MOOD, PREDICTIVE POWER 
 
Many reserve the option to seek psychological help as a last resort, meaning 
only in the direst circumstances for the most at risk individuals.  Perhaps, such a 
social stigma of psychological intervention prevents many from seeking a more 
expansive approach to obesity.  Diet and exercise is the mantra commonly used 
to describe the magic formula for weight loss, but is there not a psychological 
component to just about everything?  Psychological support is a missing element 
in many of the obesity treatments, and it does not need to be reserved for 
psychologists and psychiatrists.  Friends, family, and even the patient himself 
can be held responsible for supporting the patient.  Many studies have shown 
benefit to those individuals who incorporate positive thinking, behavioral 
modification, and group reinforcement into diet and exercise weight loss plans. 
 
In his meta-analysis of longitudinal studies to review the evidence in support of 
depression causing obesity, Blaine gives several credible points.  Blaine 
criticized how relatable the study would be to real life, the ethics of inducing a 
negative or depressed mood, but praised research teams taking into 
consideration the temporal factor and control for plausible confounding variables, 
such as the baseline BMI, age and sex (Blaine, 2008). 
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One of the major benefits to the paper published by Blaine is the consequence of 
combining 16 different studies in his computations ultimately yielding him 33,000 
subjects.  The larger scope of his examination allows him to isolate more co-
variables and draw more significant results.  He concluded the most vulnerability 
of any population lies with depressed adolescents in their likelihood of becoming 
obese, particularly adolescent female who suffer from depression.  Admittedly, 
Blaine leaves out a proposed mechanism for this causation, but presents a 
strong case nonetheless.  One critique for the studies linking depression or 
depressive episodes to an increased likelihood of emotional binge eating is 
failure to point out that only a percentage of those eat compulsively or binge eat 
develop obesity.  Certainly poor eating habits, one being binge eating, is a 
contributing factor to obesity, but it does not guarantee the result.   
 
The prospective study conducted by Goodman and Whitaker was unique and 
especially valuable because most studies up until 2002 that investigated the 
association between obesity and depression were cross-sectional studies.  
Without a measurement taken over time, it is difficult to glean insight into 
causality.  Goodman and Whitaker conducted a study of 9,374 adolescents, 
enrolled in grades 7 to 12, which incorporated in-home interviews for the National 
Longitudinal Study of Adolescent Health Assessments at the beginning of the 
study and one year later, and after controlling for low self-esteem, physical 
inactivity, parental obesity and education, they found a significant positive 
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correlation between depressed mood, diagnosed in the beginning of the study by 
the interview, and the appearance of obesity in those who were not obese initially 
(Goodman et al., 2002).  In fact, depressed individuals were twice as likely to 
become obese.  Inversely, in those individuals who were obese at the outset of 
the study, a worsening of self-esteem was observed (Goodman et al., 2002). 
Additional value is seen in this review because it focuses on adolescents, who 
have been identified as one of the most at risk groups for both obesity and 
depression. Rosmond along with others have echoed the findings of Goodman in 
his paper for the role of depression promoting obesity (Rosmond, 2004). 
Table 6 modified from Goodman et al., 2002.  AOR indicates adjusted odds ratio 
from logistic regression model. These odds ratios are adjusted for all other 
variables in the model. These odds ratios are adjusted for all other variables in 
the model. 
 
Correlates of Baseline Obesity 
   AOR   95% CI 
Age                                0.94 0.88, 1.01 
Male gender                      1.77 1.45, 2.17 
Race     
  White, non-Hispanic           1   
  Black, non-Hispanic              1.94 1.51, 2.48 
  Hispanic                        1.33  0.98, 1.80 
Two parents in the home           1.06 0.81, 1.38 
Number of obese parents             2.8 2.43, 3.22 
Increasing parental education      0.76 0.69, 0.83 
Depressed mood at baseline          0.9 0.62, 1.30 
Interestingly, depression was not associated with baseline obesity as indicated 
by the 0.9 AOR, seen in Table 6.  Race, Black and Hispanic showed strongest 
correlation, and whether or not the parents were obese were two factors 
associated with a higher chance of adolescent obesity at the beginning of the 
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Goodman study.  Ultimately, baseline obesity versus obesity developed in a year 
played a role in association with depression (Goodman et al., 2002).  In future 
studies, this distinction should be investigated further, and as a result, this may 
strengthen evidence for depression predicting obesity.  
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DEPRESSION-MOLECULAR MEDIATORS 
 
Depression caused by inflammation, resulting in elevated inflammatory markers, 
is where many researchers seek to strengthen support for the association 
between obesity and depression. Tumor necrosis factor-alpha (TNF-α) and 
Interleukin-6 (IL-6) are a good place to begin the discussion of inflammatory 
markers.  In the literature, they are well studied with respect to adiposity.  High 
levels of TNF-α are expressed in adipose while weight loss is correlated with 
diminished levels of TNF-α, high amounts of IL-6 in the blood are positively 
related to being overweight, and adiponectin, a protein secreted by adipocytes, is 
inversely correlated to central obesity, risk of diabetes, and vascular 
complications stemming from diabetes (Ikeoka et al., 2010).  Therefore, levels of 
these inflammatory markers may be used as indicators of obesity. 
 
Other important cytokines produced in the adipose include IL-1β, IL-1β receptor 
antagonist, IL-8, IL-10, and monocyte chemoattractant protein-1 (MCP-1).  High 
levels of IL-1, which acts to reduce or inflammation, are identified in the obese; in 
the same manner, obese individuals show an over-expression of IL-10, and as a 
result, IL-10 is thought to share the function of IL-1 (Ikeoka et al., 2010).  These 
markers, IL-1 and IL-10, may be signals the body is attempting to quell the level 
of inflammation already present in the obese person.  Elevated serum 
concentrations of MCP-1 are correlated with obesity as well (Ikeoka et al., 2010).  
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For the most part, a heightened level of inflammatory markers is seen, leading 
some to conclude obesity is a condition of deregulation. The inflammatory 
response, in this instance triggered by obesity, is a controlled by lengthy list of 
regulatory elements, some of which were named above.  Each of these 
molecules exerts its amplified effect in the direction of more or less inflammation. 
When pro-inflammatory effectors and anti-inflammatory regulators are 
upregulated, one sees inflammatory effects overwhelm the body.  
 
Originally, leptin was thought to be a satiety peptide, targeting the hypothalamus 
to regulate food intake.  Obese individuals were thought to develop a resistance 
to leptin, causing elevated levels in the circulatory system, and translating into an 
increased desire to ingest food (Carter et al., 2013). Leptin may have other 
functions as well, such as upregulating IL-6 and TNF-α in monocytes prompted 
by lipopolysaccharide (Miller, 2003).  Even though the role originally assigned to 
leptin in obese individuals may not be accurate, leptin still may be a key player in 
the story. 
 
A different study focusing on leptin derived a model consistent with a theory 
relating depression, weight gain, and inflammation. Miller and his team of 
investigators posed two pathways for this course of action.  Both pathways begin 
with depressive symptoms leading to weight gain as other studies have 
concluded.  In the first pathway, as adipose tissue grows, IL-6 is rapidly produced 
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and released at increasing levels, eventually traveling to the liver, which, 
upregulates C-reactive protein (CRP); in the second pathway, growing adipose 
tissue emits high amounts of leptin into the blood stream (Miller et al., 2003).  
 
 
Figure 2 taken from Miller et al., 2003.  Final Version of the Joint Pathway 
Model.  Ovals represent the medical condition linked by arrows, a proposed 
directional relationship.  * = statistically significant path at p<.05, *** = statistically 
significant path p<.001. 
 
This leptin binds to white blood cells and vascular endothelial cells inducing IL-6 
production and thus, release of CRP from hepatocytes (Miller, 2003).  Though 
Miller was unable to directly link this state of depression with the elevated 
inflammatory markers seen in depressed patients noted by many researchers. 
 
Figure 3 looks very similar to Figure 2.  There are a few key points to be noted 
between these two models.  First, the arrow connecting depression and 
inflammation is bidirectional, meaning depression may directly cause elevated 
levels of inflammatory factors, especially IL-6, TNF-α, and CRP in patients 
without previously diagnosed inflammatory diseases (Shelton et al., 2011).  Also, 
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inflammation is not shown to cause obesity, instead it is shown only as stemming 
from obesity.  This model of obesity does more to include all potential 
relationships that exist between depression, inflammation, and obesity. 
 
Figure 3 taken from Shelton et al., 2011.  The Obesity-Inflammation-Depression 
Cycle. 
 
Moreover, Shelton offers some evidence and proposes a mechanism for how 
inflammation could lead to depression.  Administration of inflammatory factors, 
such as, interferon-α has been documented to cause depression in a high 
percentage of patients (Shelton et al., 2011). To explain how cytokines could 
modify the Central Nervous System to ultimately display depression, Shelton et 
al., proposed several mechanisms:  First, local pro-inflammatory cytokines excite 
peripheral afferent nerve fibers, which stimulate microglia to produce cytokines in 
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the brain, second, holes in the blood brain barrier allow peripheral inflammatory 
molecules to pass to the brain, third, inflammatory molecules can pass through 
the blood brain barrier via active diffusion, lastly, TNF-α can induce microglia to 
produce MCP-1, which then draws monocytes to the brain, and after the 
cytokines reach the brain, they affect many of the pathways that are also 
physiologically altered in depression (Shelton et al., 2011).  Inflammation may be 
the key step missing in the pathway linking obesity with depression, but much 
contention remains whether the evidence is conclusive.  Further investigation is 
needed, especially focusing on what happens with obesity and depression as a 
result of treatment targeting inflammation. 
 
Cortisol is different from the other molecular mediators mentioned thus far 
because cortisol is an anti-inflammatory molecule.  Cortisol functions as the 
hormone produced in response to stress and works along the hypothalamic-
pituitary-adrenal (HPA) axis.  Abnormal levels are seen in many endocrine 
conditions whose phenotypes include obesity.  Therefore, any paper focusing on 
cortisol is using a unique approach and warrants a closer look. Over-activity of 
the HPA axis precedes several abnormal endocrine conditions, which promote 
central adiposity and ultimately cause inflated amounts of glucocorticoids, such 
as cortisol (Stunkard et al., 2003).  High levels of cortisol, hypercortisolemia, are 
also found in patients suffering from major depression, so this group of 
researchers decided to investigate a potential link between hypercortisolemia in 
 
 
37 
 
depressed individuals and visceral fat (Weber-Hamann et al., 2002).  They did 
find greater amounts of visceral fat in hypercortisolemic depressed patients 
compared to normocortisolemic depressed patients, suggesting levels of cortisol 
may in fact impact the extent of fat accumulation (Weber-Hamann et al., 2002).   
 
Lastly, beyond sharing a role in inflammation and the HPA axis, evidence has 
been presented that depression and obesity share another pathway, a 
neurobiological pathway.  Studies administering traditional anti-depressants or a 
placebo to obese persons showed some significant results.  Dexfenfluramine, a 
serotoninergic drug, or a placebo was given to 822 obese patients, and 6 months 
later, on average a higher collective weight loss was observed in those patients 
taking the dexfenfluramine (Guy-Grand et al., 1989).   In a different study 
spanning 2 years, 43 % of those administered sibutramine, a serotonin 
norepinephrine reuptake inhibitor, kept their weight off, 80% of their weight loss 
or greater, compared to 16% of those administered the placebo (James et al., 
2000).  Yet a different study compared the short-term effects of sertraline, a 
selective serotonin reuptake inhibitor, with a placebo. After 6 weeks, participants 
given sertraline lost significantly more weight (Rosmond, 2004).  Serotonin 
appears to be the common thread in all three studies, as each drug alters levels 
of serotonin in the brain. Because these drugs were originally discovered in 
treatment for depression and they have also shown to have significant effects on 
weight, a case can be made to the level of shared pathophysiology.  The results 
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warrant further investigation into serotonergic anti-depressant medications to be 
included in obesity treatment, especially in obese patients with a family history or 
a history of a traumatic event, although they may not be diagnosed with 
depression (Rosmond et al., 2004). 
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CONCLUSION 
 
All things considered, what is the best way to move forward?  Evidence 
presented here uncovers many potential narratives to how obesity and 
depression are related. However, a lack of conclusive evidence has a prevented 
a firm consensus from being issued from the scientific community whether 
obesity is promotes depression or vice versa, one place to start is consistency in 
defining obesity and depression. The framework of the discussion may be too 
broad.  Disagreement in the definition of obesity may account for some of the 
discrepancy.  Compared to the well-established definition of obesity as having a 
BMI of 30 kg/m2 or above, there is a less common definition of obesity offered by 
the US Public Health Service, as a BMI at or above the 85 percentile (Onyike et 
al., 2003).  Earlier studies defined obesity relative to a population as being a 
certain amount above a designated weight  (Freidman et al., 1995). For example, 
studies designated obesity as 20% or above their ideal weight, while 30% was 
the distinction employed by other studies. Others are focusing on central 
adiposity for results because it is the most hazardous and thus, where much of 
the pathology may be happening.   
 
Similarly, most preliminary population studies didn’t derive their definition for 
depression from a uniform standardized criteria (Onyike et al., 2003).  The 
importance of standardizing the definition employed by investigators lies in the 
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validity and consistency of the results across a collection of studies.  Perhaps if 
one group of researchers who concluded that obese people were just as likely as 
non-obese people to develop depression altered how depression was diagnosed 
or an aspect of its definition, then the data may support a different conclusion.  
Specifically, the span with which it takes the healthcare professionals to diagnose 
depression may be quite impactful; some studies elected to measure depression 
over a month and others over a year (Onyike et al., 2003).  The study parameters 
using baseline obesity compared to obesity developed throughout the course of 
the study could also influence outcome of results (Goodman et al., 2002).  
Researchers should look to other studies with a similar designation to 
standardize results.  Uniformity in definition criteria could filter out much of the 
insignificant results. 
 
In addition to inconsistency among researchers with respect to the definition of 
obesity, perhaps too much heterogeneity exists within the obese population 
being studied, and as a result subgroups within the obese population may be 
more appropriate to links.  Gender is one factor playing a significant role in the 
outcome of many of the studies. Many researchers have concluded a relationship 
between obesity and depression more often with women (Stunkard et al., 2003). 
In contrast, some studies failed to prove a significant association between 
obesity and depression, but after dividing the participants of the study further into 
subgroups of vary degrees of obesity, the most severely obese did show a 
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corollary to developing psychological problems (Friedman et al., 1995). Such 
findings would suggest that it may be beneficial to consider risks within the 
specific subgroups, and as currently constructed, many of the studies are 
designed to examine an obese population too broadly. 
 
Above all other questions, one remains; does a strong correlation exist between 
obesity and depression?  Unfortunately, there simply is not a consensus to be 
drawn from all the evidence presented, and finding which condition predates the 
other in an individual suffering from both may prove to be a chicken or egg 
expedition.  It is plausible an obese person might develop a more sedentary 
lifestyle and as the activities they once enjoyed dwindle, a depression may set in.  
Such a model, exemplified in figures 2 and 3, are an entirely reasonable 
explanation.  Yet it is also entirely possible for a depression to promote inactivity, 
poor eating habits, a low self-worth, and anhedonia, which ultimately lead to 
obesity.  Arguments with strong evidence has been presented for both lines or 
reasoning.  Physiologically, finding the magical pathway where obesity and 
depression line up has shown to be just as arduous.  Both conditions share 
aspects of the inflammatory pathway, HPA axis, cortisol pathway, and 
neurobiological pathways.  Which pathway has amassed more evidence of 
support is also too difficult to surmise at this point, and further investigation will 
be key in uncovering this story.   
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FUTURE RESEARCH 
 
What must not be forgotten is the reason fueling all the research in the first place.  
The growing obese population in the United States and the world, the economic 
burden that obesity places on the healthcare’s fiscal infrastructure, and the 
elevated risk for peripheral diseases such as diabetes placed on individuals by 
obesity mandate the attention of healthcare (CDC, 2003).  The goal was to frame 
the discussion of obesity within the context of a person’s psyche, specifically 
depression.   The rationales behind such a framework is to tackle this problem in 
a way different than traditionally handled before and offer key data to healthcare 
providers on how best to slow growing trend.  This point is highlighted by a group 
of authors conducting a review on how best to educate medical students to help 
change lifestyles of their obese patients.   Their review is predicated on 
prevention, identifying the most at-risk among those who are already obese, and 
encouraging doctors to enhance their role and seize opportunities to discuss 
lifestyle behavior modifications (Chisholm et al., 2012). The importance of this 
type of discussion cannot be understated. 
 
Thus far in the narrative, most of the time has been dedicated to what causes 
obesity, and subsequently, which condition comes first amongst individuals who 
are depressed and obese. But if we shift the focus to the other end of the disease 
course to the treatment, a lot of valuable information can be seen.  In other 
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words, why not work backwards?  One could evaluate the most effective 
strategies, see how they work, and in the process, maybe even gain insight into 
preventative methods.  
 
Less expensive self-help strategies are proving to be an effective method or 
component of weight loss treatment that address the prevalence of refractory 
weight gain (Latner et al., 2001), This type of strategy is based on the premise 
that obesity due to overconsumption of food is caused by disturbances in the 
psyche (Stevenson, 1978).  Participants receive useful information through a 
newsletter, manuals, classes, and noncommercial and commercial groups; they 
learn adaptive skills and internalize useful advice from peers who’ve been 
through a similar experience (Latner et al., 2001).    Health-Related Quality Of 
Life (HRQOL) may also improve as a result of being in a supportive group with 
group members likely feeling less ashamed (Wright, 2012). Self-help programs 
give the person a sense of power and inner fortitude that allows them to better 
control them and their environment, and consequently, the individual assumes a 
more active role in their weight loss and enjoys a greater self worth (Latner, 
2001).  With this empowerment through elevated self-efficacy and self-esteem, 
the patient may realize the extend to which their own actions affect the outcome 
of the weight loss.  Success of programs like these, not only in aiding those who 
want to lose weight but also preventing refractory weight gain, exemplifies the 
importance of dealing with the psychological issues of those who are overweight 
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and obese.  Self-help programs invest so much into building a person’s self-
confidence and self-control.  The question begs to be asked how low or 
depressed is the person’s self-esteem to lead to this state.  The role of the group 
and trained peers replaces the psychologist, but the effect is nearly the same, 
facing their inner problems and helping people help themselves.   
 
The idea of self-help through the influence of groups or a network is an example 
of a larger concept, termed social support. Emotional, instrumental, informational, 
and appraisal support would all fit under the umbrella of social support.  Sources 
of social support may be from family members, friends, colleagues, church 
communities, or health professionals (Verheijden et al., 2005).  How social 
support impacts health can be described using two models.  In the indirect 
model, social support alters the way an individual assesses and responds to 
stress, argued by some to be accomplished by a reduction in stress hormone 
cortisol, and in the other model, the direct model, social support influences 
psychological and physical aspects of health, irrespective of stress (Verheijden et 
al., 2005).  Regardless of which model you favor, or where the individual seeks 
this support out, the importance of social support is being brought to the forefront 
of health issues and specifically, weight loss.  There is a lot of evidence to 
confirm the effectiveness of social support.  Perhaps the most important point 
that warrants further exploration is not the exact model of how depression affects 
obesity or the inverse relationship, but it is the fact weight loss treatments for 
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those who are overweight and obese that build mental wellness seem to yield the 
best results.  And this is truly the ultimate goal. 
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